English | Español
Patient Daily | Dec 27, 2025

Johns Hopkins team develops targeted therapy for TRBC2-positive T-cell cancers
Patient Daily | Dec 27, 2025

Pfizer reports patient death during long-term trial of approved hemophilia therapy
Patient Daily | Dec 27, 2025

Neurocrine's valbenazine misses key goals in phase III cerebral palsy trial
Patient Daily | Dec 27, 2025

Novo Nordisk secures FDA approval for first oral obesity treatment
Patient Daily | Dec 27, 2025

Investment banker charged with leaking pharma M&A secrets in insider trading case
Patient Daily | Dec 26, 2025

Advances made in protecting oxygen-sensitive gut bacteria for future therapies
Patient Daily | Dec 26, 2025

Tree nut snacks shown to reduce food cravings among young adults at metabolic risk
Patient Daily | Dec 25, 2025

Cryo-EM study reveals key mechanisms for designing selective NPFFR1 ligands

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug